Alternative cancer cell fuel source targeted as therapeutic approach for breast cancer
Scientists at The Wistar Institute characterized an inhibitor that targets acetate metabolism in cancer cells. Cancer cells use acetate metabolism
Read more
Statins may protect the heart from chemotherapy treatment of early breast cancer
Statins, common cholesterol-lowering medications, may protect women’s hearts from damage caused during chemotherapy for early-stage breast cancer, according to new
Read more
New mammogram measures of breast cancer risk could revolutionise screening
World-first techniques for predicting breast cancer risk from mammograms that were developed in Melbourne could revolutionise breast screening by allowing
Read more
SABCS: Some Older Women With Breast Cancer May Opt to Skip RT
MONDAY, Dec. 14, 2020 — The omission of radiotherapy (RT) does not affect overall survival at 10 years after breast
Read more
Q&A: Breast cancer screening and COVID-19
DEAR MAYO CLINIC: During a breast self-exam two months ago, I felt a lump. This month, the lump seems to
Read more
The Warrior: Inspiring tale of consultant breast surgeon LIZ O'RIORDAN
The Warrior: Inspiring story of consultant breast surgeon LIZ O’RIORDAN five years on from losing her career, her breast and
Read more
‘Molecular clock’ blood test could track spread of breast cancer
A blood test to watch breast cancer’s ‘molecular clock’ could help track the growth of multiple tumours around the body
Read more
FDA Approves Merck’s Keytruda (pembrolizumab) in Combination With Chemotherapy for Patients With Locally Recurrent Unresectable or Metastatic Triple‑Negative Breast Cancer Whose Tumors Express PD-L1 (CPS ≥10)
KENILWORTH, N.J.–(BUSINESS WIRE) November 13, 2020 — Merck (NYSE: MRK), known as MSD outside the United States and Canada, today
Read moreStudy Updates Risks for Breast Cancer Associated With HRT
THURSDAY, Oct. 29, 2020 — Long-term use of estrogen-only and combined estrogen and progestogen hormone replacement therapy (HRT) is associated
Read more
Researchers find source of breast tumor heterogeneity and pathway that limits emergence
A key hurdle in treating breast cancers is intratumoral heterogeneity, or the presence of multiple different cell populations within the
Read more